Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence
A Randomized Longitudinal Intervention Study to Assess the Efficacy and Feasibility of Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence and Health Literacy Among Cancer Patients.
1 other identifier
interventional
128
1 country
1
Brief Summary
Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2015
CompletedFirst Posted
Study publicly available on registry
September 7, 2015
CompletedStudy Start
First participant enrolled
November 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedResults Posted
Study results publicly available
July 19, 2021
CompletedJuly 22, 2021
July 1, 2021
4.4 years
September 3, 2015
May 25, 2021
July 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication Adherence at Baseline and 6-month Follow-up Period
The participant's cancer medication adherence was taken at baseline and within a 6-month follow-up period. We measured the participant's self-efficacy with medication adherence increase with their OCAs using the SEAMS scale. SEAMS Scale: 21 items scale, ranges from 21-63, higher scores indicate higher level of self-efficacy for medication adherence.
Baseline and at 6 months
Secondary Outcomes (1)
Health Literacy at Baseline and 6-month Follow-up Period
Baseline and at 6 months
Study Arms (2)
Nurse Coach Intervention
ACTIVE COMPARATORThe nurse coach conducted an initial assessment with the participant and identified specific adherence strategies tailored to the participant's needs. The educational strategies include information about the patient's cancer treatment and expected outcomes; clear instructions about medication dosing schedule; what to do if a dose is missed or delayed; medication side effects and/or potential drug interactions; and review of cancer health literacy infographics. The behavioral skills and affective support strategies include coping strategies for side effects, skills for fitting medication regimen into daily routine, identifying a support network, communication skills for interacting with providers, and facilitating a positive perception for effective self-management experience. Patients received weekly phone calls from the nurse coach during the first month of the intervention, and then bi-monthly follow-up calls for the remainder of treatment or 6-month follow-up period.
Control
NO INTERVENTIONPatients received standard of care.
Interventions
Participants randomized to the intervention 2 group a tailored nurse coach component. Participants will receive an initial session conducted by the nurse coach, via phone or in-person. Participants will receive weekly phone calls from the nurse coach during the first month of the intervention, and then bi-monthly follow-up calls for the remainder of treatment or 6-month follow-up period (whichever occurs first). The nurse coach will modify the intervention plan to address identified barriers to adherence at this time.
Eligibility Criteria
You may qualify if:
- New cycle or withing the first 3 cycles of OCAs
- Ambulatory
- Age 18 years or older
- Able to consent for self
- Able to read and speak English
- Has a working cellphone or landline.
You may not qualify if:
- Life expectancy \<3 months as determined by oncologist
- Current participation in a similar study or in investigational drug trials where adverse effects have not been fully elucidated
- Presence of significant psychiatric or cognitive impairments as determined by oncologists and study teams.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vidant Medical Center
Greenville, North Carolina, 27587, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Essie Torres
- Organization
- East Carolina University
Study Officials
- PRINCIPAL INVESTIGATOR
Essie Torres, PhD, MPH
East Carolina University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants were randomized into the control or intervention group.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 3, 2015
First Posted
September 7, 2015
Study Start
November 15, 2015
Primary Completion
March 30, 2020
Study Completion
December 31, 2020
Last Updated
July 22, 2021
Results First Posted
July 19, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share